X Ray News and Research

RSS

Scientists reveal atomic-level view of genetic defect that causes myotonic dystrophy type 2

Scientists from the Florida campus of The Scripps Research Institute have revealed an atomic-level view of a genetic defect that causes a form of muscular dystrophy, myotonic dystrophy type 2, and have used this information to design drug candidates with potential to counter those defects—and reverse the disease.

6 Jan 2014

University of Illinois Hospital & Health Sciences System to open new Mile Square Health Center

The University of Illinois Hospital & Health Sciences System will open the doors to a new Mile Square Health Center Jan. 6.

5 Jan 2014

Carestream Health awarded $70.2M contract extension for medical imaging systems

Carestream Health has been awarded an extension of its contract with the U.S. Defense Department that allows the federal government and federal agencies to spend up to $70.2 million for digital radiography and computed radiography medical imaging systems.

3 Jan 2014

Overweight children face increased risk of asthma

Overweight and obesity are significant risk factors for reduced lung function in school-aged children with a history of early childhood wheezing, according to a study carried out at the University of Eastern Finland. The results also showed that the use of inhaled corticosteroids for asthma in childhood may result in reduced bone mineral density in early teenage years.

2 Jan 2014

Scientists obtain detailed molecular structure of member of Tet family of enzymes

Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes.

28 Dec 2013

Unprecedented, atom-scale simulation of G protein-coupled receptor site's transformation

Roughly 40 percent of all medications act on cells' G protein-coupled receptors (GPCRs). One of these receptors, beta 2 adrenergic receptor site (B2AR), naturally transforms between two base configurations; knowing the precise location of each of approximately 4,000 atoms is crucial for ensuring a snug fit between it and the drug.

28 Dec 2013

MD Now opens new urgent care center in Sunrise, Florida

MD Now Medical Centers, the fastest growing Urgent Care company in Florida today announced the opening of its newest urgent care in Sunrise, Florida at the corner of West Oakland Park and Nob Hill Road.

27 Dec 2013

Value-based medicine gains momentum

When Tanner Martin, 17, developed excruciating back pain last year, he was sure he needed an X-ray to find out what was wrong…But Konnie Martin was no ordinary parent. As chief executive officer of San Luis Valley Regional Medical Center in Alamosa, Colorado, she is at the center of an experiment, known as value-based insurance, that could transform American healthcare.

20 Dec 2013

Submicrometer line focusing reduces protein crystal damage, enhances drug development

New recommendations for using X-rays promise to speed investigations aimed at understanding the structure and function of biologically important proteins - information critical to the development of new drugs.

20 Dec 2013

Researchers discover molecular "switch" in receptor that controls cell behavior

If scientists can control cellular functions such as movement and development, they can cripple cells and pathogens that are causing disease in the body.

17 Dec 2013

Fat mass not linked to lung function in children with asthma

A study suggests that the relationship between body mass and lung function in children with asthma is more nuanced than previously thought.

16 Dec 2013

Nucletron installs first Esteya electronic brachytherapy system for skin cancer treatment

The first Esteya electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site.

From Elekta 16 Dec 2013

Experts develop innovative technologies to improve healthcare and border security

With a solemn ceremony organized on December 11, 2013 NCBJ concluded the 85.5 million PLN worth "AiD" R&D project co-financed by European Union. Project outcomes include 3 demonstrators of innovative medical devices (Coline 6, IntraLine, and InLine PN50) and 2 demonstrators of cargo scanners developed to improve security at European border crossing checkpoints (SWAN and CANIS).

13 Dec 2013

Names of 2014 Breakthrough Prize winners in Fundamental Physics and Life Sciences unveiled

The names of the 2014 Breakthrough Prize winners in Fundamental Physics and Life Sciences were unveiled at an exclusive ceremony at the NASA Ames Research Center, Mountain View, CA. At a total awarded amount of $21 million, sponsored by Sergey Brin & Anne Wojcicki, Jack Ma & Cathy Zhang, Yuri & Julia Milner and Mark Zuckerberg & Priscilla Chan, the prizes aim to celebrate scientists and generate excitement about the pursuit of science as a career.

13 Dec 2013

Research shows that person's skull is insufficient to make positive ID of human remains

Forensic experts have long used the shape of a person's skull to make positive identifications of human remains.

12 Dec 2013

FDA grants indication for GORE VIABAHN Endoprosthesis to treat thrombotic occlusion

W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts.

11 Dec 2013

Viewpoints: Optimism about Obamacare; 834 errors; can-you-keep-your-doctor debate

This was the week when liberals decided that it was safe to feel optimistic about Obamacare again. ... A worst-case scenario, in which the website remained unusable well into the new year, seems to have been averted, and with it the danger that insurers or Congressional Democrats would begin to bail on Obamacare entirely.

10 Dec 2013

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.

9 Dec 2013

New research finds that H7N9 still mainly adapted for infecting birds, not humans

Avian influenza virus H7N9, which killed several dozen people in China earlier this year, has not yet acquired the changes needed to infect humans easily, according to a new study by scientists at The Scripps Research Institute. In contrast to some initial studies that had suggested that H7N9 poses an imminent risk of a global pandemic, the new research found, based on analyses of virus samples from the Chinese outbreak, that H7N9 is still mainly adapted for infecting birds, not humans.

6 Dec 2013

New research offers fresh insights to drug designers searching for better pain treatments

In a technical tour de force, UC San Francisco scientists have determined, at near-atomic resolution, the structure of a protein that plays a central role in the perception of pain and heat.

5 Dec 2013